Viridian Therapeutics Stock (NASDAQ: VRDN) stock price, news, charts, stock research, profile.
You can purchase shares of Viridian Therapeutics (NASDAQ:VRDN) through any online brokerage.
Other companies in Viridian Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Arcutis Biotherapeutics (NASDAQ:ARQT), Day One Biopharmaceutical (NASDAQ:DAWN), CareDx (NASDAQ:CDNA) and Xencor (NASDAQ:XNCR).
Viridian Therapeutics has a consensus price target of $38.73.
The stock price for Viridian Therapeutics (NASDAQ: VRDN) is $18.41 last updated January 21, 2025 at 4:00 PM EST.
There are no upcoming dividends for Viridian Therapeutics.
Viridian Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Viridian Therapeutics.
Viridian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.